Valsartan Cancers Revealed
Several drug companies have voluntarily recalled their blood pressure and heart medication containing valsartan. Researchers discovered that the drug is contaminated with the impurity, N-nitrosodimethylamine or NDMA. NDMA can cause cancer. Now, scientists pinpoint the full range of valsartan cancers and are also urging people to keep their potentially contaminated medications for testing. About Valsartan Manufactured
Read More
Second Carcinogen Discovered in Valsartan Medications
The FDA has identified yet another contaminate in valsartan containing drugs found in several popular cardiovascular drugs. In July, the FDA discovered the first contaminate and issued a recall. Now, three more lots of the drugs contain a second impurity, N-Nitrosodiethylamine, or NDEA, which can also cause cancer. About Valsartan Manufactured by Major Pharamascetucials,
Read More
Valsartan Recall Due To Cancer Risk
The FDA has issued a recall for Diovan, Diovan HCT, Exforge, Exforge HCT and Entresto from multiple manufacturers. Researchers discovered that these drugs could be contaminated with N-nitrosodimethylamine or NDMA. NDMA can cause liver cancer. About Valsartan Manufactured by Major Pharamascetucials, Teva Pharmaceuticals, and other companies, valsartan is a cardiovascular drug to treat high blood pressure
Read More